Drug-eluting Stents versus PTA with GP IIb/IIIa Blockade Below the Knee in Patients with Current Ulcers: The BELOW-Study

Abstract Archives of the RSNA, 2008

SSQ23-03

Drug-eluting Stents versus PTA with GP IIb/IIIa Blockade Below the Knee in Patients with Current Ulcers: The BELOW-Study—Long-term Follow Up

Scientific Papers

Presented on December 4, 2008
Presented as part of SSQ23: Vascular/Interventional (Peripheral Arterial Interventions: Alive and Well(?) in Radiology)

Participants

Gunnar Tepe MD, Abstract Co-Author: Research Consultant, Johnson & Johnson Research Consultant, Cook Group Incorporated Research Consultant, sanofi-aventis Group Research Consultant, Abbott Laboratories Research Consultant, Bayer AG

Stephan Heller, Abstract Co-Author: Nothing to Disclose

Klaus Brechtel MD, Abstract Co-Author: Nothing to Disclose

Claus Detlef Claussen MD, Abstract Co-Author: Nothing to Disclose

Stephan Hoyt Duda MD, Abstract Co-Author: Nothing to Disclose

Michael Christian Fenchel MD, Presenter: Nothing to Disclose

PURPOSE

METHOD AND MATERIALS

RESULTS

CONCLUSION

CLINICAL RELEVANCE/APPLICATION

Sirolimus eluting stents result result in a higher patency rate in small arteries below the knee. This was followed by a 80% heeling rate of ulcerations in critical limb ishemia patents.

Cite This Abstract

Tepe, G, Heller, S, Brechtel, K, Claussen, C, Duda, S, Fenchel, M, Drug-eluting Stents versus PTA with GP IIb/IIIa Blockade Below the Knee in Patients with Current Ulcers: The BELOW-Study—Long-term Follow Up. Radiological Society of North America 2008 Scientific Assembly and Annual Meeting, February 18 - February 20, 2008 ,Chicago IL. http://archive.rsna.org/2008/6011613.html